| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.79B | 132.81B | 168.19B | 160.65B | 123.20B | 107.78B |
| Gross Profit | 49.03B | 39.77B | 53.91B | 50.89B | 38.94B | 32.70B |
| EBITDA | 13.96B | 7.66B | 16.88B | 16.06B | 7.93B | 6.19B |
| Net Income | 10.54B | 1.03B | 12.60B | 17.92B | 6.44B | 3.73B |
Balance Sheet | ||||||
| Total Assets | 190.41B | 173.48B | 199.61B | 253.17B | 205.10B | 166.99B |
| Cash, Cash Equivalents and Short-Term Investments | 57.79B | 42.89B | 54.39B | 51.67B | 50.85B | 51.71B |
| Total Debt | 10.58B | 10.79B | 10.88B | 11.80B | 14.39B | 14.45B |
| Total Liabilities | 74.58B | 54.93B | 82.43B | 141.46B | 115.98B | 83.47B |
| Stockholders Equity | 115.82B | 118.54B | 117.17B | 111.70B | 89.12B | 83.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -10.96B | 5.62B | 6.20B | -1.35B | 10.05B |
| Operating Cash Flow | 0.00 | -8.46B | 8.33B | 9.31B | 934.00M | 11.30B |
| Investing Cash Flow | 0.00 | -1.82B | 910.00M | -3.81B | -563.00M | -1.26B |
| Financing Cash Flow | 0.00 | -3.51B | -6.53B | -6.70B | -2.28B | -2.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥134.05B | 16.49 | ― | 3.24% | 8.95% | 18.54% | |
74 Outperform | ¥93.86B | 17.51 | 7.00% | 3.02% | 8.49% | -0.33% | |
73 Outperform | ¥56.55B | 14.37 | ― | 2.54% | 3.47% | -12.26% | |
71 Outperform | ¥92.61B | 14.50 | 9.39% | 1.68% | 7.26% | 28.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥85.27B | 27.20 | 5.02% | 3.23% | -21.03% | -91.77% |